Sign in

You're signed outSign in or to get full access.

Nishan Sarna

Vice President and Equity Research Analyst at Citigroup Global Markets Holdings Inc.

Nishan Sarna is a Vice President and Equity Research Analyst at Citigroup, specializing in the coverage of the industrial sector with a focus on large-cap machinery, engineering, and industrial technology companies such as Caterpillar, Deere & Company, and Cummins. With a strong background in financial analysis and valuation, Sarna is recognized for insightful company-specific recommendations and has achieved robust forecast accuracy on platforms like TipRanks, maintaining an estimated success rate of around 65% with consistent outperformance compared to sector peers. He began his career as an investment banking analyst at Barclays before joining Citi in 2018, where he has advanced through various research roles. Nishan holds FINRA Series 7 and Series 63 licenses, underlining his commitment to professional standards and industry best practices.

Nishan Sarna's questions to BioNTech (BNTX) leadership

Question · Q1 2025

Nishan Sarna, on behalf of Geoff Meacham, asked about the key factors and rationale driving the selection of specific combination therapies, such as ADCs and cell therapies, to be paired with BNT327.

Answer

CEO Ugur Sahin detailed a three-part strategy: 1) combining with other IO pipeline assets like bispecifics, 2) combining with mRNA vaccines to target residual disease, and 3) combining with their ADC portfolio to reduce tumor burden and leverage immunogenic cell death, a concept for which they have preclinical proof of concept.

Ask follow-up questions

Fintool

Fintool can predict BioNTech logo BNTX's earnings beat/miss a week before the call